Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5
Revision as of 15:10, 20 May 2020 by Maintenance script (talk | contribs)
Bibliography entry in "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8; DOI: https://doi.org/10.1038/s41392-020-0110-5
| Title | FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia |
|---|---|
| DOI | 10.1158/1078-0432.CCR-19-0365 |
| 1st AU | Norsworthy Kelly J. |
| 2nd AU | By Kunthel |
| 3rd AU | Zhuang Luning |
| 4th AU | Del Valle Pedro L. |
| 5th AU | Przepiorka Donna |
| 6th AU | Shen Yuan-Li |
| 7th AU | Sheth Christopher M. |
| 8th AU | Liu Chao |
| 9th AU | Leong Ruby |
| PubDate | 2019 |
| Journal | Clinical Cancer Research |
| Volume | 25 |
| Issue | 20 |
| Page(s) | 6021-6025 |
| Cited In | Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5) |
